Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Revenue" stands at 64.24 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Merck & Company Inc's third quarter result of 17.28 Billion USD for the item "Total Revenue" represents an increase of 9.30 percent compared to it's second quarter result.
Also, Merck & Company Inc's third quarter result of 17.28 Billion USD for the item "Total Revenue" represents an increase of 3.72 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 64.24 Billion USD for the item "Total Revenue" represents an increase of 0.97 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.68 percent compared to the value the year prior.
The 1 year change in percent is 1.68.
The 3 year change in percent is 8.92.
The 5 year change in percent is 45.31.
The 10 year change in percent is 61.54.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Revenue | 280,205,508,085.11 |